A Study on the Clinical Course, Outcomes and Risk Factors of Myocarditis and Pericarditis After Moderna COVID-19 Vaccine

Conditions: Myocarditis, Pericarditis Interventions: Biological: mRNA-1273 Sponsors: ModernaTX, Inc.; Lead Scientific and Operating Center: Julius Clinical Research Active, not recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials